Senhwa Biosciences, Inc. (TPEX:6492)
Taiwan
· Delayed Price · Currency is TWD 50.80
+0.85 (1.70%)
Apr 29, 2026, 10:40 AM CST
Senhwa Biosciences Market Cap
Senhwa Biosciences has a market cap or net worth of 4.46 billion as of April 28, 2026. Its market cap has increased by 31.40% in one year.
Market Cap
4.46B
Enterprise Value
3.72B
Revenue
1.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
50.80
Market Cap Chart
Since December 4, 2014, Senhwa Biosciences's market cap has decreased from 6.81B to 4.46B, a decrease of -34.45%. That is a compound annual growth rate of -3.64%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medigen Biotechnology | 4.44B |
| ACRO Biomedical | 4.29B |
| Pharmosa Biopharm | 4.88B |
| OBI Pharma | 4.14B |
| Formosa Pharmaceuticals | 4.11B |
| UnicoCell Biomed | 5.14B |
| Sagittarius Life Science | 4.01B |
| Steminent Biotherapeutics | 5.20B |